Towards Healthcare Research & Consulting
Non-Steroidal Anti-Inflammatory Drugs Market
Updated Date: 08 July 2026   |   Report Code: 5132
[email protected] +1 804-441-9344
Download Sample Order Now

Non-Steroidal Anti-Inflammatory Drugs Market Trends, Share, and Growth Analysis 2035

According to Shivani Zoting, who specializes in pharmaceuticals and healthcare market research, with 5+ years of experience in market research and industry analysis, the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is set for steady expansion, growing from USD 23.16 billion in 2025 to USD 37.73 billion by 2035 at a 5% CAGR. Her analysis identifies arthritis, oral NSAIDs, and retail pharmacies as the leading market segments, while North America maintains its dominant position and Asia Pacific emerges as a key growth region. She also highlights how innovation in drug delivery and competition among major companies, including Pfizer, Merck, Novartis, Bayer, Johnson & Johnson, Dr. Reddy's Laboratories, Viatris, AstraZeneca, GlaxoSmithKline, and Abbott Laboratories, continue to shape the market's competitive landscape.

Last Updated : 08 July 2026 Category: Therapeutic Area Insight Code: 5132 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Cancer Vaccines Market Assessment

  • Overview
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Cancer Vaccines Market Assessment

  • Overview
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Europe Cancer Vaccines Market Assessment

  • Overview
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Asia Pacific Cancer Vaccines Market Assessment

  • Overview
  • Asia Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Asia Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Asia Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Middle East and Africa Cancer Vaccines Market Assessment

  • Overview
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

South America Cancer Vaccines Market Assessment

  • Overview
  • South America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • South America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • South America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Company Profiles

  • Pfizer Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Merck & Co., Inc.
  • Novartis AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc.
  • Bayer AG
  • Dr. Reddy's Laboratories Ltd.
  • Viatris Inc
  • AstraZeneca
  • Abbott Laboratories

Conclusion & Recommendations

FAQ's

Answer : The NSAIDs market is projected to rise from USD 23.16 billion in 2025 to USD 24.32 billion in 2026 and reach USD 37.73 billion by 2035, driven by a steady 5% CAGR.

Answer : Arthritis remains the top contributor, capturing 38% of the market due to its high global prevalence, especially among aging adults.

Answer : World Health Organization, Food and Drug Administration, National Institute of Health, ScienceDirect, PubMed.gov.
Any Questions

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar